Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence
K Sandhanam,
No information about this author
Tamilanban Thamaraikani,
No information about this author
K. Manasa
No information about this author
et al.
Neuroscience,
Journal Year:
2024,
Volume and Issue:
553, P. 1 - 18
Published: June 27, 2024
Language: Английский
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(4), P. 471 - 471
Published: April 4, 2025
Noncoding
RNAs
(ncRNAs)
are
a
heterogeneous
group
of
RNA
molecules
whose
classification
is
mainly
based
on
arbitrary
criteria
such
as
the
molecule
length,
secondary
structures,
and
cellular
functions.
A
large
fraction
these
ncRNAs
play
regulatory
role
regarding
messenger
(mRNAs)
or
other
ncRNAs,
creating
an
intracellular
network
cross-interactions
that
allow
fine
complex
regulation
gene
expression.
Altering
balance
between
interactions
may
be
sufficient
to
cause
transition
from
health
disease
vice
versa.
This
leads
possibility
intervening
in
mechanisms
re-establish
patients.
The
associated
with
all
cancer
hallmarks,
proliferation,
apoptosis,
invasion,
metastasis,
genomic
instability.
Based
function
performed
carcinogenesis,
behave
either
oncogenes
tumor
suppressors.
However,
this
distinction
not
rigid;
some
can
fall
into
both
classes
depending
tissue
considered
target
molecule.
Furthermore,
them
also
involved
regulating
response
traditional
cancer-therapeutic
approaches.
In
general,
molecular
by
very
still
largely
unclear,
but
it
has
enormous
potential
for
development
new
therapies,
especially
cases
where
methods
fail,
their
use
novel
more
efficient
biomarkers.
Overall,
review
will
provide
brief
overview
human
biology,
specific
focus
describing
most
recent
ongoing
clinical
trials
(CT)
which
have
been
tested
therapeutic
agents
evaluated
Language: Английский
NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway
Yingnan Li,
No information about this author
Mengjiao Shi,
No information about this author
Beibei Bie
No information about this author
et al.
Journal of Hepatocellular Carcinoma,
Journal Year:
2025,
Volume and Issue:
Volume 12, P. 891 - 908
Published: May 1, 2025
DDX11
antisense
RNA
1
(DDX11-AS1)
has
been
recognized
for
its
strong
correlation
with
hepatocellular
carcinoma
(HCC).
Nevertheless,
the
exact
biological
functions
and
fundamental
molecular
processes
of
DDX11-AS1
in
HCC
require
further
in-depth
investigation.
A
comprehensive
bioinformatics
analysis
was
carried
out
to
explore
expression
clinical
implication
utilizing
TCGA
data.
qRT-PCR
employed
validate
tissues/cell
lines.
fluorescence
situ
hybridization
(RNA-FISH)
used
observe
subcellular
localization
cells.
Loss-of-function
experiments,
both
vitro
vivo,
were
executed
elucidate
HCC.
sequencing
(RNA-seq)
identify
genes
signaling
pathways
potentially
regulated
by
DDX11-AS1.
Rescue
experiments
conducted
that
carbonic
anhydrase
IX
(CA9)
mediates
promoting
progression.
The
influence
nuclear
respiratory
factor
(NRF1)
on
transcription
investigated
through
dual-luciferase
reporter
assays
ChIP-qPCR.
increased
is
positively
associated
several
aggressive
characteristics
(pathologic
T
stage,
histologic
grade,
AFP
level,
vascular
invasion),
closely
linked
unfavorable
outcomes
patients,
acting
as
a
separate
hazardous
overall
survival.
predominantly
situated
nucleus
knockdown
impeded
growth,
migration,
invasion
capabilities
cells
vitro,
reduced
tumor
enlargement
subcutaneous
mouse
model.
RNA-Seq
unveiled
silencing
lessened
CA9
suppressed
activity
MEK/ERK
cascade
uncovered
acts
downstream
target
facilitating
cancer-causing
roles
Furthermore,
revealed
be
transcriptionally
NRF1.
DDX11-AS1,
NRF1-induced
lncRNA,
facilitates
development
upregulating
activating
cascade.
Language: Английский
YRNAs: biosynthesis, structure, functions and involvment in cancer development
Adele Campo,
No information about this author
Federica Aliquò,
No information about this author
Tania Velletri
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 13, 2025
Language: Английский
siRNA-based knockdown of lncRNAs; a new modality to target tumor progression
Pathology - Research and Practice,
Journal Year:
2024,
Volume and Issue:
266, P. 155746 - 155746
Published: Nov. 28, 2024
Language: Английский
Identification of exosomal ceRNA networks as prognostic markers in clear cell renal cell carcinoma
Medicine,
Journal Year:
2024,
Volume and Issue:
103(43), P. e40167 - e40167
Published: Oct. 25, 2024
Aggressive
clear
cell
renal
carcinoma
(ccRCC)
has
a
bad
prognosis.
We
seek
new
ccRCC
biomarkers
for
diagnosis
and
treatment.
used
exoRBase
The
Cancer
Genome
Atlas
Database
to
compare
DEmRNAs,
DEmiRNAs,
DElncRNAs,
DEcircRNAs
in
normal
tissues.
CircRNAs
circRNAs
targeting
microRNAs
(miRNAs)
were
anticipated
taken
intersections,
several
databases
assessed
the
targeted
link
between
common
miRNAs
messenger
RNAs
(mRNAs).
database
was
create
predictive
mRNA
signature
that
validated
E-MTAB-1980.
Finally,
we
examined
competing
endogenous
RNA
network
long
noncoding
using
overall
survival
analysis.
built
first
regulation
of
circRNA–lncRNA–miRNA–mRNA
found
it
substantially
correlates
with
unveiled
ccRCC’s
posttranscriptional
mechanism
greater
detail.
Our
findings
identified
novel
diagnosis,
therapy,
Language: Английский
Expression of the lncRNA TPT1-AS1 in lung squamous cell carcinoma and its prognostic value
Lixin Yu,
No information about this author
Zhenkui Zhang,
No information about this author
Zhijian Wang
No information about this author
et al.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 11, 2024
Lung
squamous
cell
carcinoma
is
typically
associated
with
a
poor
prognosis,
highlighting
the
need
for
reliable
prognostic
marker.
Given
that
long
noncoding
RNA
TPT1-AS1
has
demonstrated
aberrant
expression
in
numerous
cancers,
significance
of
LUSC
was
examined.
Language: Английский